Reviva Pharmaceuticals, Inc. — Form D
Reviva Pharmaceuticals, Inc. of SAN JOSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2016-07-25. The offering totals $5.0M, of which $1.2M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-07-25
- Form: D
- Accession: 0001552470-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $5.0M
- Amount sold: $1.2M
- Remaining: $3.8M
- Minimum investment: $25K
- Investors: 16
- Date of first sale: 2016-07-11
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-267657
Issuer
- Name: Reviva Pharmaceuticals, Inc.
- CIK: 0001552470
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 5941 OPTICAL COURT, SAN JOSE, CA, 95138
- Phone: 408-960-2209
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Laxminarayan Bhat | Director | SAN JOSE, CA |
| Sarvajna Dwivedi | Director | Santa Clara, CA |
| Pedr Jensen | Director | Santa Clara, CA |
| Laxminarayan Bhat | Executive Officer | SAN JOSE, CA |
| Marc Cantillon | Executive Officer | Santa Clara, CA |
Other filings by this issuer (3)
More